The Supreme Court is scheduled to consider in March the issue of whether all blood banks should mandatorily conduct Nucleic Acid Test (NAT) for the identification of diseases.The bench of CJI Surya Kant and Justice Joymalya Bagchi was hearing a PIL seeking directions for the implementation of mandatory NAT testing across all blood banks in the country. Notably, the Nucleic Acid Test (NAT) is...